Oaktree Capital

Superinvestor

Oaktree Capital Management LP

SEC CIK: 0000949509
Manager: Howard Marks
Style: Value
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CLDI holding history

Calidi Biotherapeutics, Inc. in every 13F filed by Oaktree Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDI overview All 13F holders of CLDI Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2021

Holdings of CLDI by Oaktree Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−300,000−100.0%	Sold out	Holders
Q2 2022	300,000	$2.98M	<0.1%	00.0%	Unchanged	Holders
Q1 2022	300,000	$2.97M	<0.1%	00.0%	Unchanged	Holders
Q4 2021	300,000	$2.95M	<0.1%	+300,000	New	Holders